---
title: "Novo Nordisk's Ozempic recommended for use in the EU for the treatment of arterial disease"
description: "Novo Nordisk announced on Monday that the European Commission has recommended the use of its type 2 diabetes and obesity drug Ozempic for the treatment of peripheral artery disease (PAD) and its main "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/245769409.md"
published_at: "2025-06-23T20:22:59.000Z"
---

# Novo Nordisk's Ozempic recommended for use in the EU for the treatment of arterial disease

> Novo Nordisk announced on Monday that the European Commission has recommended the use of its type 2 diabetes and obesity drug Ozempic for the treatment of peripheral artery disease (PAD) and its main therapeutic issues. The company stated that it expects the European Commission to update the drug's label in about two months

Novo Nordisk (NVO.US) announced on Monday that the European Commission has recommended the use of its type 2 diabetes and obesity drug Ozempic for the treatment of peripheral artery disease (PAD) and its primary therapeutic issues.

The company stated that it expects the European Commission to update the drug's label in about two months

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| US sugar industry weighs impact from new dietary guidelines regulation | The U.S. sugar industry is facing potential impacts from new dietary guidelines that may reduce domestic sugar demand. S | [Link](https://longbridge.com/en/news/276479104.md) |
| As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/en/news/270794581.md) |
| Cruise operator Carnival to unify dual listing | Carnivalannounced plans to unify its dual listings in New York and London and redomicile to Bermuda. The UK-listed Carni | [Link](https://longbridge.com/en/news/276491689.md) |
| Insider Selling: Atlassian (NASDAQ:TEAM) CTO Sells 3,072 Shares of Stock | Atlassian Corporation PLC CTO Rajeev Bashyam Rajan sold 3,072 shares of stock at an average price of $81.35, totaling $2 | [Link](https://longbridge.com/en/news/276497817.md) |
| Tempus AI EVP Erik Phelps Sells Shares | Erik Phelps, EVP and Chief Admin. Officer of Tempus AI, sold 9,464 shares of Class A Common Stock on February 19, 2026,  | [Link](https://longbridge.com/en/news/276495655.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.